Company / Book Value per Share
Edwards Lifesciences Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$17.802
FY2025
5-year range
$9.351 / $17.802
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#66 of 158
Health Care
What the data says
At $17.802, Edwards Lifesciences's book value per share ranks #66 of 158 in the Health Care sector. Book Value per Share has increased for 5 consecutive years, from $7.327 in FY2020 to $17.802 in FY2025.
Based on SEC 10-K filings.
$17.802 in FY2025 with a 5-year CAGR of +19.4%.
Improved from $10.932 to $17.802 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +23.1%
- 5-Year CAGR
- +19.4%
- 10-Year CAGR
- -
Sector benchmark
#66 of 158 in Health CareTop 42% of 158This company $17.802 Sector average $48.175
▼
-63.0% below sector average
Key checks
Key Insights
- Edwards Lifesciences's book value per share has grown for 5 consecutive years.
- 5-year CAGR of +19.4%, indicating consistent growth.
- In FY2025, book value per share increased 7.0% year-over-year.
- Ranks #66 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.802 | +7.0% |
| FY2024 | $16.634 | +52.2% |
| FY2023 | $10.932 | +14.5% |
| FY2022 | $9.546 | +2.1% |
| FY2021 | $9.351 | +27.6% |
| FY2020 | $7.327 | -63.1% |
| FY2019 | $19.839 | +31.2% |
| FY2018 | $15.12 | +8.2% |
| FY2017 | $13.971 | +12.9% |
| FY2016 | $12.377 | -46.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026